Bernhard KohlClimbing expert Bernhard Kohl is the latest rider to test positive for CERA, a variant of the blood booster erythropoietin (EPO). The announcement was made by France’s anti-doping agency (AFLD). The Austrian rider took the best climber’s jersey and finished third overall.

All the blood samples taken during the 2008 Tour de France held this July will be tested for CERA. It has only been a few weeks ago that a new testing method was developed to detect  this third-generation blood booster thus the retroactive testing.

An AFLD statement issued Monday said that Kohl had been notified of the result.

“The AFLD confirms that it’s laboratory at Châtenay-Malabry has found two abnormal samples showing the presence of EPO CERA in blood samples taken on July 3 and 15, before and during the Tour de France, on Austrian cyclist Bernard Kohl,” the statement said. “The official notification to the athlete was done through the Austrian Anti-doping Agency (NADA Austria).

This means disciplinary proceedings can be taken against the athlete by the French and Austrian national disciplinary authorities, as the 2008 Tour de France was not included in the UCI (world cycling’s governing body) calendar.”